IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
32 hedge funds and large institutions have $22.3M invested in Impel Pharmaceuticals Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
32
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$10.8K | |
| 2 | +$3.76K | |
| 3 | +$724 | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$4 |
Top Sellers
| 1 | -$101K | |
| 2 | -$41K | |
| 3 | -$38.9K | |
| 4 |
Renaissance Technologies
New York
|
-$17K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.87K |